Investigational Drug Information for Varespladib
✉ Email this page to a colleague
What is the development status for investigational drug Varespladib?
Varespladib is an investigational drug.
There have been 11 clinical trials for Varespladib.
The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2010.
The most common disease conditions in clinical trials are Syndrome, Snake Bites, and Anemia, Sickle Cell. The leading clinical trial sponsors are Anthera Pharmaceuticals, Ophirex, Inc., and Premier Research International LLC.
Summary for Varespladib
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 101 |
| WIPO Patent Applications | 98 |
| Japanese Patent Applications | 19 |
| Clinical Trial Progress | Phase 2 (2010-05-01) |
| Vendors | 52 |
Recent Clinical Trials for Varespladib
| Title | Sponsor | Phase |
|---|---|---|
| Broad-spectrum Rapid Antidote: Varespladib IV to Oral Trial for Snakebite (BRAVIO) | Ophirex, Inc. | Phase 2 |
| Broad-spectrum Rapid Antidote: Varespladib Oral for Snakebite | Premier Research International LLC | Phase 2 |
| Broad-spectrum Rapid Antidote: Varespladib Oral for Snakebite | Ophirex, Inc. | Phase 2 |
Clinical Trial Summary for Varespladib
Top disease conditions for Varespladib
Top clinical trial sponsors for Varespladib
US Patents for Varespladib
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
